The week in health tech, explained in plain English.Get the free newsletter →
October 23, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

For Big Payers, Insurance Is No Longer the Whole Point

The nation's largest health insurers keep drifting away from insurance as their main growth engine, and second-quarter earnings make the shift clearer than ever, according to Becker's Hospital Review.

UnitedHealth Group and Elevance Health, which reported earlier in the earnings cycle, increasingly depend on their services arms rather than premiums alone. UnitedHealth's Optum spans pharmacy benefits, care delivery, and data analytics, and rivals have built or bought similar businesses. These units carry different economics than traditional insurance and have become where the biggest players keep directing investment.

The pressure is practical. Rising medical costs, especially in Medicare Advantage, are compressing margins on core insurance products. Diversified services offer steadier, higher-margin revenue that is less exposed to claims volatility. For the industry, it signals that the biggest payers now see themselves as integrated healthcare conglomerates, not just insurers, with growing influence over pharmacies, clinics, and the data that shapes care decisions.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.